Amicus Therapeutics Inc. buy Wells Fargo & Company
Start price
20.02.25
/
50%
€8.70
Target price
20.02.26
€16.27
Performance (%)
36.78%
End price
21.02.26
€11.90
Summary
This prediction ended on 21.02.26 with a price of €11.90. With a performance of 36.78% the BUY prediction by Wells_Fargo___Compan was a big success. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -3.750% | -3.750% | 106.239% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.90
30.05.24
30.05.24
€16.62
30.05.25
30.05.25
-39.89%
31.05.25
31.05.25
